You are here: Industry Insights > COVID-19

News List

Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children prnewswire
October 16, 2020
Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at ...
Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID- prnewswire
October 16, 2020
Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, announced results of the ILIAD Study (Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in ...
Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics prnewswire
October 16, 2020
Aetion co-authored a study published in Science, which examined lethal coronaviruses SARS-CoV-2, SARS-CoV-1, and MERS-CoV to identify molecular characteristics of potential treatments.
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies worldpharmanews
October 16, 2020
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that...
NIHR review identifies long-term effects of COVID-19 pharmatimes
October 16, 2020
A review from the National Institute for Health Research will analyse the evidence around ongoing COVID-19 symptoms, otherwise referred to as ‘Long Covid’.
BioGX Announces EUA for Extraction-Free Direct RT-PCR Test for COVID-19 americanpharmaceuticalreview
October 16, 2020
BioGX announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
Abbott Receives EUA for COVID-19 IgM Antibody Blood Test americanpharmaceuticalreview
October 16, 2020
Abbott announced the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT? and Alinity? platforms.
RedHill Biopharma Ramps-Up Manufacturing of Opaganib contractpharma
October 16, 2020
?RedHill Biopharma Ltd., a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently in global Phase 2/3 and ...
Faceless assessment causes delay in customs clearance expresspharma
October 16, 2020
The Central Board of Indirect Taxes and Customs (CBIC)’s promotion of ‘Faceless, Contactless, Paperless Customs’ is resulting in delays of import-export shipment clearances.
Trial supports use of fluvoxamine in patients with mild COVID-19 europeanpharmaceuticalreview
October 16, 2020
A clinical trial has demonstrated that the likelihood of hospitalisation was significantly reduced for patients with mild COVID-19 when given fluvoxamine.